Effectiveness of biological prosthesis for femoro-femoral bypass in high risk patients

Sukovatykh B.S.

Kursk State Medical University

SPIN RSCI: 8778-1530
Scopus AuthorID: 7004581366
ORCID: 0000-0003-2197-8756

Belikov L.N.

City Clinical Hospital of Emergency Medical Assistance, Kursk, Russia

Rodionov A.O.

Chair of General Surgery, Kursk State Medical University of Healthcare Ministry of the Russian Federation, Kursk, Russia

Sukovatykh M.B.

Kafedra obshcheĭ khirurgii Kurskogo gosudarstvennogo meditsinskogo universiteta

Grigorian A.Yu.

Chair of General Surgery, Kursk State Medical University of Healthcare Ministry of the Russian Federation, Kursk, Russia

Effectiveness of biological prosthesis for femoro-femoral bypass in high risk patients

Authors:

Sukovatykh B.S., Belikov L.N., Rodionov A.O., Sukovatykh M.B., Grigorian A.Yu.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2018;(5): 86‑90

DOI: 10.17116/hirurgia2018586-90

Downloaded: 30

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Sukovatykh BS, Belikov LN, Rodionov AO, Sukovatykh MB, Grigorian AYu. Effectiveness of biological prosthesis for femoro-femoral bypass in high risk patients. Pirogov Russian Journal of Surgery. 2018;(5):86‑90. (In Russ.)
https://doi.org/10.17116/hirurgia2018586-90

Подписка 2025 (Pirogov Russian Journal of Surgery)

Close metadata

Aim. To compare synthetic and biological prostheses for femoral bypass surgery. Material and methods. There were 40 patients with critical ischemia of lower extremities due to atherosclerotic lesion of aorto-iliac segment and severe comorbidities. They were divided into 2 groups by 20 patients. C-shaped femoro-femoral bypass with synthetic polytetrafluoroethylene and lavsan prostheses was performed in the first group and S-shaped bypass procedure with biological prosthesis from the internal thoracic arteries of the bull — in the second group. Results. Biological prosthesis is associated with reduced early postoperative morbidity by 10%, late graft thrombosis incidence by 20% and increased physical and psychological health by 7.1%. Conclusion. S-shaped femoro-femoral bypass with a biological prosthesis from the internal thoracic arteries of the bull is pathogenetically substantiated and effective.

Keywords:

critical ischemia

lower extremities

femoro-femoral bypass

synthetic polytetrafluoroethylene and lavsan prostheses

biological prosthesis from the internal thoracic arteries of the bull

Authors:

Sukovatykh B.S.

Kursk State Medical University

SPIN RSCI: 8778-1530
Scopus AuthorID: 7004581366
ORCID: 0000-0003-2197-8756

Belikov L.N.

City Clinical Hospital of Emergency Medical Assistance, Kursk, Russia

Rodionov A.O.

Chair of General Surgery, Kursk State Medical University of Healthcare Ministry of the Russian Federation, Kursk, Russia

Sukovatykh M.B.

Kafedra obshcheĭ khirurgii Kurskogo gosudarstvennogo meditsinskogo universiteta

Grigorian A.Yu.

Chair of General Surgery, Kursk State Medical University of Healthcare Ministry of the Russian Federation, Kursk, Russia

List of references:

Park KM, Park YJ, Kim YW, Hyun D, Park KB, Do YS, Kim DI. Long term outcomes of femorofemoral crossover bypass grafts. Vascular Specialist International. 2017;33(2):55-58. https://doi.org/10.5758/vsi.2017.33.2.55
Thuijls G, van Laake LW, Lemson MS, Kitslaar PJ. Usefulness and applicability of femorofemoral crossover bypass grafting. Annals of Vascular Surgery. 2008;22(5):663-667. https://doi.org/10.1016/j.avsg.2008.04.002
Sukovatykh BS, Belikov LN, Rodionov OA, Rodionov AO. Efficiency of bioprosthesis in case of axillary-femoral bypass in patients with high operative risk. Khirurgiya. 2014;6:8-12. (In Russ.)
Blaisdell FW. Development of femoro-femoral and axillo-femoral bypass procedures. Journal of Vascular Surgery. 2011;53:540-544. https://doi.org/10.1016/j.jvs.2010.06.018
Ricco JB, Probst H. Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease. Journal of Vascular Surgery. 2008;47(1):45-53. https://doi.org/10.1016/j.jvs.2007.08.050
Capoccia L, Riambau V, da Rocha M. Is femorofemoral crossover bypass an option in claudication? Annals of Vascular Surgery. 2010;24(6):828-832. https://doi.org/10.1016/j.avsg.2010.03.021
Conte MS. Bypass versus angioplasty in severe ischemia of the leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia. Journal of Vascular Surgery. 2010;51:69-75. https://doi.org/10.1016/j.jvs.2010.02.001
Pursell R, Sideso E, Magee TR, Galland RB. Critical appraisal of femorofemoral crossover grafts. British Journal of Surgery. 2005;92(5):565-569. https://doi.org/10.1002/bjs.4880
Sukovatykh BS, Vedenev YI, Rodionov AO. Comparative characteristics of the wound process in the arterial wall after implantation of synthetic and biological endoprostheses. Novosti Khirurgii. 2013;21(3):9-15. (In Russ.)
Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Lones DN. Recommended standarts for reports dealing with lower extremity ischemia: Revised version. Journal of Vascular Surgery. 1997;26:516-538.

Close metadata